In this study we conducted a prospective cohort study on the incidence of anti-PF4/polyanionic antibodies, thrombocytopenia, and thrombosis after vaccination with the first, second or the third booster doses of ChAdOx1 nCoV-19. Here, PF4 is linked to Thrombocytopenia.